カリフォルニア州における過体重の臨床試験
カリフォルニア州内の拠点で、過体重に関する64件の研究が参加者を募集しています。
カリフォルニア州内の都市
- Concord16件の研究
- Los Angeles15件の研究
- San Diego13件の研究
- Escondido12件の研究
- El Cajon9件の研究
- Torrance9件の研究
- Santa Ana7件の研究
- Tustin7件の研究
- Sacramento6件の研究
- Long Beach5件の研究
- Huntington Beach5件の研究
- Indio5件の研究
- South Gate5件の研究
- Santa Clarita5件の研究
- Santa Monica5件の研究
- Lake Forest4件の研究
- Chula Vista4件の研究
- Simi Valley4件の研究
- Hawthorne4件の研究
- Richmond4件の研究
- Westminster4件の研究
- Ontario3件の研究
- West Covina3件の研究
- Riverside3件の研究
- Glendale3件の研究
公式研究テキスト（英語）
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
- Cedars Sinai Medical Center, Los Angeles
被験者募集中
21歳〜65歳 · 全性別 · 2026/10/01更新 · NCT07090005Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- John Muir Health - Concord /ID# 282469, Concord
- NorCal Medical Research /ID# 283117, Greenbrae
- Velocity Clinical Research - Huntington Park /ID# 282987, Huntington Park
- 他6件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07752979AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- Torrance Clinical Research Institute, Inc., Lomita
- Diablo Clinical Research, Inc., Walnut Creek
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Neighborhood Healthcare, Escondido
被験者募集中第3相
8歳〜18歳 · 全性別 · 2026/09/30更新 · NCT07253285Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Diablo Clinical Research - Flourish Research, Walnut Creek
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07685808AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Providence Medical Foundation, Fullerton
- Torrance Clinical Research Institute, Inc., Lomita
- Diablo Clinical Research, Inc., Walnut Creek
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- First Valley Medical Group, Lancaster
- Desert Oasis Healthcare, Palm Springs
- Western University of Health Sciences, Pomona
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07668414Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- Profound Research, Oceanside
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/28更新 · NCT07837973A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Orange County Research Center, Lake Forest
- Healthy Brain Clinic, Long Beach
- Los Angeles Institute for Metabolic Research, Los Angeles
- 他6件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Headlands Research California, LLC, Escondido
- ImmuniMet, LLC, Modesto
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
- Parexel International, Glendale
被験者募集中第1相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT07594093A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Escondido
- Research Site, Lincoln
- Research Site, Walnut Creek
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Loma Linda University School of Medicine, Loma Linda
- Childrens Hospital of Los Angeles, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
- 他2件
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- 他1件
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- 他1件
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Neighborhood Healthcare Institute of Health, Escondido
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Desert Oasis Healthcare Medical Group, Palm Springs
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Valley Clinical Trials, LLC dba Flourish Research, Covina
- Velocity Clinical Research- Huntington Park, Huntington Park
- Orange County Research Center, Lake Forest
- 他5件
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Irvine Clinical Research, Irvine
- Scripps Whittier Diabetes Institute, La Jolla
- EndoTrials Center for Clinical Research, La Mesa
- 他5件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07392190CHOICE to AVOID or RESIST
- Cedars-Sinai Medical Center, Beverly Hills
被験者募集中健康なボランティア歓迎
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT06521021A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Ark Clinical Research, Long Beach
- Collaborative Neuroscience Research, LLC, Los Alamitos
- Artemis Institute for Clinical Research, Riverside
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07369011A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- NorCal Medical Research, Inc, Greenbrae
- Velocity Clinical Research, Huntington Park, Huntington Park
- Peninsula Research Associates, Rolling Hills Estates
- 他1件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Wolverine Clinical Trials, Santa Ana
- Encompass Clinical Research, Spring Valley
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07353931A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- San Fernando Valley Health Institute, Canoga Park
- AMCR Institute, Escondido
- NorCal Medical Research, Inc, Greenbrae
- 他6件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Bakersfield
- Research Site, Gardena
- Research Site, Lincoln
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
- Research Site, Glendale
被験者募集中第1相健康なボランティア歓迎
35歳〜75歳 · 女性 · 2026/09/17更新 · NCT07013643A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Banning
- AURORA-1 Clinical Site, Chula Vista
- AURORA-1 Clinical Site, Covina
- 他5件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Banning
- AURORA-2 Clinical Site, Chula Vista
- AURORA-2 Clinical Site, Covina
- 他6件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Orange County Research Center, Lake Forest
- Ark Clinical Research, Long Beach
- Catalina Research Institute, LLC, Montclair
- 他3件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Wolverine Clinical Trials, Santa Ana
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/14更新 · NCT06897475A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- University of California Irvine, Irvine
- Artemis Institute for Clinical Research, LLC, San Diego
- Diablo Clinical Research, Inc., Walnut Creek
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Escondido
- ACCOMPLISH-2 Research Site, Fountain Valley
- ACCOMPLISH-2 Research Site, La Jolla
- 他4件
被験者募集中第3相健康なボランティア歓迎
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Artemis Insitute for Clin Res, San Diego
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/11更新 · NCT07571005A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
- PAREXEL Glendale/LA EPCU, Glendale
被験者募集中第1相
18歳〜55歳 · 全性別 · 2026/09/09更新 · NCT07566390Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Headlands Research California, LLC, Escondido
- National Research Institute - Huntington Park, Huntington Park
- Los Angeles Institute for Metabolic Research, Los Angeles
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07770841A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- NorCal Medical Research, Inc, Greenbrae
- Velocity Clinical Research, Huntington Park, Huntington Park
- Peninsula Research Associates, Rolling Hills Estates
- 他1件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication
- UCLA Center for Human Nutrition, Los Angeles
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/09/08更新 · NCT07806838A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- First OC Dermatology Research Inc, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Metropolis Dermatology, Los Angeles
- 他1件
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06857942Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Escondido
- Kailera Clinical Site, Toluca Lake
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284875Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Ark Clinical Research- Tustin, Fountain Valley
- Long Beach Clinical Trials Services Inc, Long Beach
- Ark Clinical Research- Long Beach, Long Beach
- 他6件
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- San Fernando Valley Health Institute, Canoga Park
- Core Healthcare Group, Cerritos
- Velocity Clinical Research Chula Vista, Chula Vista
- 他1件
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684144ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。